[Antihypertensive therapy in diabetes mellitus]

Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies.

Drug safety·2002

Increased central body fat deposition precedes a significant rise in resting blood pressure in male offspring of essential hypertensive parents: a 5 year follow-up study.

Journal of hypertension·2001

Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension.

American journal of hypertension·2001

Nephropathy subsequent to hyperlipidemia.

Clinical nephrology·2000

Hypovolemia contributes to the pathogenesis of orthostatic hypotension in patients with diabetes mellitus.

The American journal of medicine·1999

Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.

Journal of cardiovascular pharmacology·1999

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026

[Non-invasive diagnostic imaging for coronary artery disease: choosing the right test for the right patient].

Therapeutische Umschau. Revue therapeutique·2026

[Multimodality imaging in the diagnostic work-up in patients with heart failure in clinical practice].

Therapeutische Umschau. Revue therapeutique·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

[Antihypertensive therapy in diabetes mellitus]

Related Concept Videos

Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies.

Increased central body fat deposition precedes a significant rise in resting blood pressure in male offspring of essential hypertensive parents: a 5 year follow-up study.

Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension.

Nephropathy subsequent to hyperlipidemia.

Hypovolemia contributes to the pathogenesis of orthostatic hypotension in patients with diabetes mellitus.

Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

[Non-invasive diagnostic imaging for coronary artery disease: choosing the right test for the right patient].

[Multimodality imaging in the diagnostic work-up in patients with heart failure in clinical practice].

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

[Antihypertensive therapy in diabetes mellitus]

Related Concept Videos

Related Articles